Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice - Wikidata - awgldk - TriplyDB

Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice

Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice

http://www.wikidata.org/entity/Q33821025

about

Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.

P2860

Q55518174-DEC3F844-ABD6-4712-AA4E-7430C566A0A9

P2860

Mouse IP-10 Gene Delivered by Folate-modified Chitosan Nanoparticles and Dendritic/tumor Cells Fusion Vaccine Effectively Inhibit the Growth of Hepatocellular Carcinoma in Mice

http://www.wikidata.org/entity/Q33821025

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@ast

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@en

type

label

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@ast

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@en

prefLabel

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@ast

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@en

P1433

Q33821025-CBF045E9-42D0-433A-9BD7-2FBE816D5381

P1476

Q33821025-96B4463B-7F9F-415D-A5DE-3D9264222ADC

P2093

Q33821025-08B3906C-1D74-4660-A30B-5361C1F0DA4B

Q33821025-17FF4ADA-EF7B-4277-A128-156DA52A543D

Q33821025-2A28BB6E-65D1-4840-A0CC-0185E287496B

Q33821025-50C0378C-39EC-4BE0-ABFB-413A6665737A

Q33821025-7265AB07-F060-401B-9AA6-E6A06BED52F5

Q33821025-B1609916-CCEF-4DE1-ADEA-83E79E105479

Q33821025-BAA5FA1E-77D4-4DF4-8434-F86985BFBBB1

Q33821025-D1E6DA25-E522-47AB-AB14-68730A323523

Q33821025-D74311CF-51BB-4CED-A8D8-7A90E3110279

Q33821025-D7D465CD-720E-4535-B60D-C22868471AAC

P2860

Q33821025-008EF9AD-4BEF-46CB-9B01-558D9464BA7A

Q33821025-079A67BE-3509-4F25-A745-BFCE0E466F63

Q33821025-07AB4ADA-1577-4813-893A-0A7A9AFB9F20

Q33821025-0925AD1A-417A-426B-914D-20F2A2654B20

Q33821025-0ACE3806-D4D0-4B5A-8C38-96F6E10BF9A6

Q33821025-18094123-03A3-4015-8898-17707C6AB2E6

Q33821025-36498814-475F-4C23-B0C6-64EA92B30AEF

Q33821025-3AE1788E-9B7F-484A-A260-E23233176AE3

Q33821025-3B217538-55D1-4616-AE26-533C844C5344

Q33821025-3E683957-E80A-47D6-9645-FAA4998BE5EA

P304

Q33821025-22F1B674-627F-4AAB-B097-C2E1B59EF0D8

P31

Q33821025-D11C813A-FED0-41FC-972C-6FE01B0F961E

P356

Q33821025-A8603657-33C0-48D8-8A2D-2DFCA8951E20

P433

Q33821025-E8FB351F-297D-4179-B27A-FCEBBC90FB52

P478

Q33821025-3BD74435-C0C5-423B-86AE-C38DD30CBA75

P577

Q33821025-D6DBA718-7F43-4BDB-B732-F997B13AAFA1

P698

Q33821025-D4EFF62B-4304-421B-91BF-E876C1363B2F

P932

Q33821025-13850DC0-9335-472B-83C8-7312789D9BF2

P356

P1433

P1476

Mouse IP-10 Gene Delivered by ...... patocellular Carcinoma in Mice

@en

P2093

Jian He

http://www.w3.org/2001/XMLSchema#string

Jiaojiao Chen

http://www.w3.org/2001/XMLSchema#string

Jing Su

http://www.w3.org/2001/XMLSchema#string

Nuo Yang

http://www.w3.org/2001/XMLSchema#string

Siliang Duan

http://www.w3.org/2001/XMLSchema#string

Sufang Zhou

http://www.w3.org/2001/XMLSchema#string

Xiaoling Lu

http://www.w3.org/2001/XMLSchema#string

Yongxiang Zhao

http://www.w3.org/2001/XMLSchema#string

Zhenghua Zhang

http://www.w3.org/2001/XMLSchema#string

Zhiyong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Development and novel therapeutics in hepatocellular carcinoma: a review

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.

TUNEL-positive cells in the surgical border of an amputation due to infected diabetic foot.

Specific protection against breast cancers by cyclin D1 ablation.

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice.

High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART

The immunosuppressant Protosappanin A diminished recipient T cell migration into allograft via inhibition of IP-10 in rat heart transplant.

The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy.

Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.

P304

1942-1952

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.16236

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28638480

http://www.w3.org/2001/XMLSchema#string

P932

5479281

http://www.w3.org/2001/XMLSchema#string